Диссертация (1174314), страница 29
Текст из файла (страница 29)
Immunohistochemicallabeling of steroid receptors in normal and malignant human endometrium // ActaHystochem. – 2009. – Vol.111. – №4. – P.349-359.220. Ness R.B. Endometriosis and ovarian cancer: thoughts on sharedpathophysiology // Am J Obstet Gynecol. – 2003. – Vol.189. – P.280-294.221. Nouri K., Ott J., Krupitz B. et al. Family incidence of endometriosis in first-,second-, and third-degree relatives: case-control study // Reprod Biol Endocrinol. –2010. – Vol.11. – №8. – P.85-92.222. Ohlsson Teague E.M.C., Van der Hoek K.H., Van der Hoek M.B.
et al.MicroRNA-regulated pathways associated with endometriosis // Endocrinol. – 2009. –Vol.23. – P.265-275.223. Osuga Y., Koqa K., Hirota Y. et al. Lymphocytes in endometriosis // Am JReprod Immunol. – 2011. – Vol.65. – №.1. – P.1-10.170224. Othman EE-D., Hornung D., Salem H.T.
et al. Serum cytokines asbiomarkers for nonsurgical prediction of endometriosis // Eur J Obstet Gynecol ReprodBiol. – 2008. – Vol.137. – P.240-246.225. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and theregulation of tissue remodeling // Nat Rev Mol Cell Bioll. – 2007. – Vol.8. – №3. –P.221-233.226. Pan Q., Luo X., Toloubeydokhti T., Chegini N. The expression profile ofmicro-RNA in endometrium and endometriosis and the influence of ovarian steroids ontheir expression //Mol Hum Reprod. – 2007.
– Vol.13. – P.797-806.227. Pelletier G., El-Alfy M. Immunocytochemical localization of estrogenreceptors alpha and beta in the human reproductive organs // J Clin Endocrinol. – 2000.– Vol.85. – №12. – P.4835-4840.228. Peluso J.J., Romak J., Liu X. Progesterone receptor membrane component-1(PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneouslyimmortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acidtreatment and functional analysis of PGRMC1 mutations // Endocrinology. – 2008.
149(2). – P.534-543.229. Philip, C.A. Performances and place of sonography in the diagnostic ofendometriosis: CNGOF-HAS Endometriosis Guidelines / C.A. Philip, G. Dubernard //Gynecol Obstet Fertil Senol. - 2018. - №46 (3). – Р.185-199.230. Pizzo A., Salmeri F.M., Ardita F.V. et al.
Behaviour of cytokine levels inserum and peritoneal fluid of women with endometriosis // Gynecol Obstet Invest. –2002. –№54. – P.82-87.231. Practice Committee of American Society of Reproductive Medicine(ASRM). Treatment of pelvic pain associated with endometriosis // Fertil Steril. – 2008.– Vol.90. – P.341-269.232. Raine-Fenning N., Jayaprakasan K., Deb S. Three-dimensional ultrasoundcharacteristics of endometriomata // Ultrasound Obstet Gynecol.
– 2008. – Vol.31. –№6. – P.718-724.171233. Raffi F., Metwally M., Amer S. The impact of excision of ovarianendometrioma on ovarian reserve: a systematic review and meta-analysis // J ClinEndocrinol Metab. – 2012. – Vol.97. – №9. – P.3146-3154.234. Ramon L.A., Braza-Boils A., Gilabert-Estelles J. et al.
MicroRNAsexpression in endometriosis and their relation to angiogenic factors // Hun Reprod. –2011. – Vol.26. – №5. – P.1082-1090.235. Roman H., Pura I., Tarta O. et al. Vaporization of ovarian endometriomausing plazma energy: Histologic findings of a pilot study // Fertil Steril. – 2011. –Vol.95. – P.1853-1856.236. Romao G.S., Navarro P.A., Ferriani R.A.
et al. Serum anti-Mullerianhormone to predict ovarian response in assisted reproduction cycles // Rev Bras GinecolObstet. – 2012. – Vol.34. – №12. – P.575-581.237. Rongxian J., Chow V.T.-K., Tan P.-H. et al. Metallothionein 2A expression isassociated with cell proliferation in breast cancer // Carcinogenesis. – 2002. – Vol.21. –№1. – P.81-86.238. Sasagawa S., Shimizu Y., Kami H.
et al. Dienogest is a selectiveprogesterone receptor agonist in transactivation analysis with potent oral endometrialactivity due to its efficient pharmacokinetic profile // Steroids. – 2008. – Vol.73. –P.222-231.239. Sandri M.T., Bottari F., Franchi D. et al. Comparison of HE4, CA125 andROMA algorithm in women with a pelvic mass: correlation with pathological outcome// Gynecol Oncol. – 2013. – Vol.128.
– №2. – P.233-238.240. Santulli P., Borqhese B., Chouzenoux S. Interleukin-19 and interleukin-22serum levels are decreased in patients with ovarian endometrioma // Fertil Steril. –2013. – Vol.99. – №1. – P.219-226.241. Savelli L. Transvaginal sonography for the assessment of ovarian and pelvicendometriosis: how deep is our understanding? // Ultrasound Obstet Gynecol. – 2009. –Vol.33. – №5. – P.497-501.242. Scurry J., Whitehead J., Healey M.
Classification of ovarian endometioticcysts // Int J Gnecol Pathol. – 2001. – Vol.20. – №2. – P.147-154.172243. Seeber B., Sammel M.D., Fan X. et al. Panel of markers can accuratelypredict endometriosis in a subset of patients // Fertil Steril. – 2008. – №.89. – P.10731081.244. Shaco-Levy R., Sharabi S., Benharroch D. et al. Matrix metalloproteinases 2and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrialcarcinoma and nonneoplastic eutopic endometrium // Eur J Obst Gynecol Reprod Biol.– 2008. – Vol.139. – №2.
– P.226-232.245. Shan K., Ying W., Jian-Hui Z. et al. The function of the SNP in the MMP1and MMP3 promoter in susceptibility to endometriosis in China // Mol Hum Reprod. –2005. – Vol.11. – №6. – P.423-427.246. Shanmugam N., Reddy M.A., Natarajan R. Distinct roles of heterogeneousnuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stabilityinduced by S100b, a ligand of the receptor for advanced glycation and products // J BiolChem. – 2008.
– Vol.283. – №.301. – P.36221-36233.247. Sharpe-Timms K.L., Zimmer R.L., Jolliff W.J. et al. Gonadotropin-releasinghormone agonist (GnRH) therapy alters activity of plasminogen activators, matrixmetalloproteinases, and their inhibitors in rat models for ashesion formation andendometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation //Fertil Steril. – 1998. – Vol.69.
– №5. – P.916-923.248. Shimizu Y., Takeuchi T., Mita S. et al. Dienogest, a synthetic progestin,inhibits the proliferation of immortalized human endometrial epithelial cells withsuppression of cyclin DI gene expression // Mol Hum Reprod. – 2009. – Vol.15. –P.693-701.249. Shindler A.E. Gonadotropin-releasing hormone agonists for prevention ofpostoperative adhesions: overview // Gynecol Endocrinol.
– 2004. – Vol.19. – №1. –P.51-55.250. Signorile P.G., Baldi A. Endometriosis: new concepts in the pathogenesis //Int J Biochem Cell Biol. – 2010. – Vol.42. – №6. – P.778-780.173251. Sikora J, Smycz-Kubanska M., Mielczarek-Palacz A. et al. The involment ofmultifunctional TGF-β and related cytokines in pathogenesis of endometriosis //Immunol Lett. – 2018. – Vol.201. – №31. – P.31-37.252.
Sitruk-Ware R. Pharmacological profile of progestins // Maturitas. – 2004. –Vol.47. – P.277-283.253. Smuc T., Hevir N., Ribic-Puceli M. et al. Distrurbed estrogen andprogesterone action in ovarian endometriosis // Mol Cell Endocrinol. – 2009. – Vol.25. –№.301. – P.1-2.254. Solomatina A.A., Kavteladze E.V., Safronova D.A., Bratchikova O.V. Threedimentional evaluation of ovarian reserve in patient with endometriomas before andafter laparoscopic excision // 11-th World Congress on Endometriosis. – France, 2011. –P.242.255.
Strowitzki T., Marr J., Gerlinger C. et al. Dienogest is as effective asleuprolide acetate in treating the painful symptoms of endometriosis: a 24-week,randomized, multicentre, open-label trial // Hum Reprod. – 2010. – Vol.25. – P.633-641.256. Strowitzki T., Faustmann T., Gerlinger C. et al. Dienogest in the treatment ofendometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebocontrolled study // Eur J Obstet Gynecol Reprod Biol. – 2010. – Vol.151. – P.193-198.257. Szubert M., Suzin J., Wierzbowski T., Kowalczyk-Amico K.
CA-125concentration in serum and peritoneal fluid in patients with endometriosis – preliminaryresults // Arch Med Sci. – 2012. – Vol.8. – №3. – P.504-508.258. Szymanowski K., Mikołajczyk M., Wirstlein P., Dera-Szymanowska A.Matrixmetalloproteinase-2(MMP-2),MMP-9,tissueinhibitorofmatrixmetalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expressionin eutopic endometrium of women with peritoneal endometriosis // Ann Agric EnvironMed. – 2016.
– Vol.23. – №4. – P.649-653.259. Sun-WeiGuo.EpigeneticofendometriosisReproduction. – 2009. – Vol.15. – №10. – P.587-607.174//MolecularHuman260. Taguchi A., Yanagisawa K., Tanaka M. et al. Identification of hypoziainducible factor-1 alpha as a novel target for miR-17 – 92 microRNA cluster // CanderRes. – 2008. – Vol.68. – P.5540-5545.261.
Tamura M., Deb S., Sebastian S. et al. Estrogen upregulates cyclooxygenase2 via estrogen receptor in human uterine microvascular endothelial cells // Fertil Steril.– №81. – P.1351-1356.262. Taylor E., Williams C. Surgical treatment of endometriosis: location andpatterns of disease at reoperation // Fertil Steril. – 2010. – Vol.93.
– №1. – P.57-61.263. Teague E.M., Print C.G., Hull M.L. The role of microRNA in endometriosisand associated reproductive conditions // Hum Reprod Update. – 2010. – Vol.16. – №2.– P.146-165.264. Thomas S., Acharya M., Muthukumar et al. Effectiveness of Anti-MullerianHormone-tailored Protocol Compared to Conventional Protocol in Women UndergoingIn vitro Fertilization: A Randomized Controlled Trial // J Hum Reprod Sci. – 2018. №11(1). – Р.24-28..265.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
